Eelke G.
- Country
- The Netherlands
- Department
- Medical Oncology
Research Overview
- Evaluation of GDC-6036 Monotherapy and Combination Therapy in Advanced or Metastatic Solid Tumors with KRAS G12C Mutation
- Evaluation of MK-1484 Monotherapy and Combination with Pembrolizumab in Adults with Advanced or Metastatic Solid Tumors
- Phase 1/2 Open‑Label Study of Oral GSK5460025A Monotherapy and Combination Therapy Assessing Safety and Efficacy in dMMR/MSI‑H Tumors, colorectal and endometrial cancer
Data & Insights
Has run more than one trial at 33 of 121 partner sites.
Specializations
Gynecologic Oncology
This investigator specializes in treating advanced and recurrent gynecological cancers, with particular focus on developing innovative therapeutic approaches for women's reproductive system malignancies.
- Endometrial cancer management
- Ovarian cancer treatment
- Cervical cancer therapies
The research encompasses comprehensive treatment of fallopian tube cancer and primary peritoneal cancer.
Therapeutic Development
The investigator focuses on evaluating novel therapeutic agents for gynecological malignancies, with emphasis on determining optimal dosing strategies and safety profiles.
- Safety assessment protocols
- Dose optimization studies
- Therapeutic tolerance evaluation
Areas of investigation include intravenous treatment administration and dose-response relationships.
Clinical Innovation
The investigator's work centers on advancing treatment options for patients with recurrent gynecological malignancies, particularly in cases where standard treatments have proven insufficient.
- Novel therapeutic approaches
- Treatment tolerability assessment
- Clinical response evaluation
Research focuses on developing targeted therapeutic strategies for gynecologic cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.